Dexcom (NSDQ:DXCM) shares took a big hit today on third-quarter results that trounced the consensus forecast.
Shares of DXCM were down nearly -9% at $346.51 per share in mid-morning trading yesterday. Today, DXCM is trading down -3.2% $338.10.
The San Diego-based insulin delivery technology developer posted profits of $72.2 million, or 73¢ per share, on sales of $500.9 million for the three months ended Sept. 30, 2020, for a 57.6% bottom-line gain on sales growth of 26.4%.
